ESR1 and breast cancer: Next, we evaluated the effect of both the GART siRNA-dependent downregulation and the GART inhibition by lometrexol (LMX) (39) in a panel of 7 ERα-positive BC cell lines characterized by different histological types and different clinical surrogates (Supplementary Table 9).